EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 93 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $7,242,000 | +9.5% | 961,700 | -8.4% | 0.02% | +20.0% |
| Q2 2022 | $6,615,000 | -53.1% | 1,050,000 | -38.2% | 0.02% | -44.4% |
| Q1 2022 | $14,110,000 | +593.4% | 1,700,000 | +580.0% | 0.03% | +440.0% |
| Q3 2020 | $2,035,000 | -57.6% | 250,000 | -50.0% | 0.01% | -58.3% |
| Q2 2020 | $4,800,000 | +265.0% | 500,000 | +158.6% | 0.01% | +200.0% |
| Q1 2020 | $1,315,000 | -96.0% | 193,374 | -91.3% | 0.00% | -95.1% |
| Q4 2019 | $33,153,000 | +45.4% | 2,225,000 | 0.0% | 0.08% | +44.6% |
| Q3 2019 | $22,806,000 | -3.3% | 2,225,000 | 0.0% | 0.06% | -5.1% |
| Q2 2019 | $23,585,000 | -5.0% | 2,225,000 | +25.4% | 0.06% | -4.8% |
| Q1 2019 | $24,815,000 | +37.6% | 1,775,000 | 0.0% | 0.06% | +24.0% |
| Q4 2018 | $18,034,000 | +120.3% | 1,775,000 | +160.2% | 0.05% | +177.8% |
| Q3 2018 | $8,186,000 | -1.6% | 682,200 | 0.0% | 0.02% | -5.3% |
| Q2 2018 | $8,323,000 | – | 682,200 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 1,787,091 | $20,462,000 | 6.02% |
| INTERWEST VENTURE MANAGEMENT CO | 1,599,592 | $18,315,000 | 3.89% |
| NEXTHERA CAPITAL LP | 263,600 | $3,018,000 | 1.54% |
| SPHERA FUNDS MANAGEMENT LTD. | 385,301 | $4,412,000 | 0.86% |
| RA Capital Management | 354,200 | $4,056,000 | 0.50% |
| DAFNA Capital Management LLC | 35,977 | $412,000 | 0.35% |
| Boxer Capital, LLC | 138,331 | $1,584,000 | 0.35% |
| SABBY MANAGEMENT, LLC | 238,907 | $2,735,000 | 0.15% |
| Monashee Investment Management LLC | 31,500 | $361,000 | 0.14% |
| Lombard Odier Asset Management (USA) Corp | 100,000 | $1,145,000 | 0.11% |